These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 7540802

  • 21. An open trial of risperidone augmentation of partial response to clozapine.
    Taylor CG, Flynn SW, Altman S, Ehmann T, MacEwan GW, Honer WG.
    Schizophr Res; 2001 Mar 01; 48(1):155-8. PubMed ID: 11345947
    [No Abstract] [Full Text] [Related]

  • 22. [Follow-up of a 16-year-old adolescent with early-onset schizophrenia and catatonic symptoms].
    Menard ML, Yagoubi F, Drici M, Lavrut T, Askenazy F.
    Encephale; 2013 May 01; 39 Suppl 1():S29-35. PubMed ID: 23219595
    [Abstract] [Full Text] [Related]

  • 23. Management of treatment resistant schizophrenia unresponsive to clozapine.
    Barnes TR, McEvedy CJ, Nelson HE.
    Br J Psychiatry Suppl; 1996 Dec 01; (31):31-40. PubMed ID: 8968653
    [No Abstract] [Full Text] [Related]

  • 24. Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group.
    Peuskens J.
    Br J Psychiatry; 1995 Jun 01; 166(6):712-26; discussion 727-33. PubMed ID: 7545060
    [Abstract] [Full Text] [Related]

  • 25. Unexpected dystonia while changing from clozapine to risperidone.
    Radford JM, Brown TM, Borison RL.
    J Clin Psychopharmacol; 1995 Jun 01; 15(3):225-6. PubMed ID: 7543499
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Withdrawal-emergent respiratory dyskinesia with risperidone treated with clozapine.
    Mendhekar DN, Inamdar A.
    J Neuropsychiatry Clin Neurosci; 2010 Jun 01; 22(2):E24. PubMed ID: 20463136
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
    Chouinard G, Jones B, Remington G, Bloom D, Addington D, MacEwan GW, Labelle A, Beauclair L, Arnott W.
    J Clin Psychopharmacol; 1993 Feb 01; 13(1):25-40. PubMed ID: 7683702
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Risperidone in the treatment of schizophrenia.
    Marder SR, Meibach RC.
    Am J Psychiatry; 1994 Jun 01; 151(6):825-35. PubMed ID: 7514366
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.